Ames negative; chromosomal aberrations in vitro; negative in vivo rat micronucleus and liver comet assays
“non-mutagenic in Ames test, increased chromosomal aberrations in vitro but not considered clastogenic in the in vivo rat micronucleus assay and did not induce DNA damage in the Comet assay in rat hepatocytes”
Not conducted (short treatment duration, generally 14 days or less)
“Carcinogenicity studies were not conducted. CHMP agreed that carcinogenicity studies were not needed as the SmPC states that the duration of dosing will be generally 14 days or less (not exceeding 21 days).”
Mouse and rat EFD: no developmental toxicity up to 2000 (mouse, SC) and 1000 (rat, IV) mg/kg/day
“Cefiderocol did not cause developmental toxicity in mice when administered to dams at daily subcutaneous doses up to 2000 mg/kg/day (twice daily 1000 mg/kg doses) from GD 6-15. It did not cause developmental toxicity in rats when administered intravenously to dams at doses up to 1000 mg/kg/day from GD 6-17.”
✓ VerifiedFDA multi-discipline review, p. 47Source ↗
Safety pharmacology
QTc prolongation in cynomolgus monkeys at 1000 mg/kg IV, in safety pharmacology and repeat-dose studies
“Prolongation of the QTc (Bazett) was observed in cynomolgus monkeys following a 1000 mg/kg dose given intravenously over 1 hour (observed in both a single dose safety pharmacology study and in repeat dose toxicology studies).”
✓ VerifiedFDA multi-discipline review, p. 47Source ↗
Not genotoxic overall: Ames negative; in vitro chromosome aberration positive without (not with) metabolic activation; rat micronucleus and comet negative